Youngevity ‘90 For Life’ Health Tour Attracts Audience of More Than 2,000 to Baltimore Convention Center on July 21
Company Executives and Top Distributors Educate Audience Members About the ‘90 For Life’ Health Message
SAN DIEGO–(BUSINESS WIRE)–Growing direct-selling conglomerate Youngevity® Essential Life Sciences announces it attracted an audience of more than 2,000 people to its ‘90 for Life’ Health Tour event at the Baltimore Convention Center in Baltimore, Maryland this past Saturday, July 21. Youngevity is a wholly owned subsidiary of AL International (JCOF)(www.alintjcof.com), a global marketer of lifestyle and nutritional products and gourmet fortified coffee.
During the event, Company executives and top distributors presented information to the audience about the ‘90 for Life’ Health Message, which emphasizes the benefits of the 90 essential nutrients at the center of Youngevity’s commitment to improving lives through science-based, high-quality nutrition. Attendees also enjoyed free makeovers featuring Youngevity Mineral Makeup. In addition, Youngevity’s direct selling leaders were recognized for their accomplishments and rank advancements.
The event was hosted by Senior Vice Chairman Marketing Director Andre Vaughn and the World Class Team. Speakers included Dr. Joel Wallach, cofounder of Youngevity; Bill Andreoli, President; Vanessa Hunter, VP of Marketing; Steve Schulz, VP of Training; Mike Randolph, VP of Leadership Development; and Dr. Peter Glidden, Youngevity Scientific Advisory Board member and leading naturopathic physician.
Steve Wallach, CEO of AL International, said, “This event represented a wonderful opportunity to educate the general public on how to live healthier and longer through proper supplementation, and specifically on the ways that Youngevity’s ‘90 For Life’ program can potentially help in achieving these goals. We were encouraged by the number of people who purchased the Youngevity Healthy Start Pack (Osteo FX Plus, EFA Plus, and Beyond Tangy Tangerine) at this event. We are pleased at the reception we received from the audience in Baltimore, and look forward to holding similar events across the country throughout the summer.”
Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.
About AL International
AL International, Inc. (PINKSHEETS: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a "network of networks." The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.Youngevity.com) and Javalution Coffee Company in the summer of 2011.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
The Investor Relations Group
Adam Holdsworth, 212-825-3210
Enrique Briz, 212-825-3210